Incorporating the patient voice in market access

The patient voice is firmly established as key to determining value in healthcare. This means that pharmaceutical and biotechnology manufacturers should evaluate and evolve how they engage with patients.

This article explores the evolving patient-centric approaches within biopharma market access, enabling you to:

  • understand how patients can be involved throughout the product lifecycle
  • determine the influence of the patient voice in regulatory and HTA activities
  • learn how manufacturers and patients/advocacy groups can work in partnership



Free download

Latest insights

The evolution of the PRMA Healthcheck®

ICER 2020 value assessment framework: 7 updates that market ...

How collaboration and connectivity can accelerate payer ...